These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30501529)

  • 21. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
    Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
    Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal diagnosis of thalassemia and Hb S syndromes in Greece: an evaluation of 1500 cases.
    Loukopoulos D; Karababa P; Antsaklis A; Panourgias J; Boussiou M; Karayannopoulos K; Politis J; Rombou D; Kaltsoya-Tassiopoulou A; Fessas P
    Ann N Y Acad Sci; 1985; 445():357-75. PubMed ID: 2409876
    [No Abstract]   [Full Text] [Related]  

  • 23. Toward providing parents the option of avoiding the birth of the first child with Cooley's anemia: response to hemoglobinopathy screening and counseling during pregnancy.
    Rowley PT; Loader S; Walden ME
    Ann N Y Acad Sci; 1985; 445():408-16. PubMed ID: 3860140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and control of thalassemia at Saraburi Regional Hospital.
    Chareonkul P; Kraisin J
    J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of thalassemia.
    Loukopoulos D; Kaltsoya-Tassiopoulou A; Fessas P
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1419-27. PubMed ID: 6316486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid detection of fetal Mendelian disorders: thalassemia and sickle cell syndromes.
    Traeger-Synodinos J; Vrettou C; Kanavakis E
    Methods Mol Biol; 2008; 444():133-45. PubMed ID: 18425477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of hemoglobinopathies in Egypt.
    El-Beshlawy A; Youssry I
    Hemoglobin; 2009; 33 Suppl 1():S14-20. PubMed ID: 20001619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain.
    Modell B; Petrou M; Ward RH; Fairweather DV; Rodeck C; Varnavides LA; White JM
    Lancet; 1984 Dec; 2(8416):1383-6. PubMed ID: 6150377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal diagnosis of hemoglobinopathies in Tunisia: an 18 years of experience.
    Ouali F; Siala H; Bibi A; Hadj Fredj S; Dakhlaoui B; Othmani R; Ouenniche F; Zouari F; Bouguerra B; Rezigua H; Fattoum S; Messaoud T
    Int J Lab Hematol; 2016 Jun; 38(3):223-32. PubMed ID: 26993054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre Gestational Thalassemia Screening in Mainland China: The First Two Years of a Preventive Program.
    Jiang F; Chen GL; Li J; Xie XM; Zhou JY; Liao C; Li DZ
    Hemoglobin; 2017; 41(4-6):248-253. PubMed ID: 29124982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single centre study on birth of children with transfusion-dependent thalassaemia in Malaysia and reasons for ineffective prevention.
    Ngim CF; Ibrahim H; Lai NM; Ng CS
    Prenat Diagn; 2015 Jan; 35(1):51-9. PubMed ID: 25156332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delay between pregnancy confirmation and sickle cell and [corrected] thalassaemia screening: a population-based cohort study.
    Dormandy E; Gulliford MC; Reid EP; Brown K; Marteau TM;
    Br J Gen Pract; 2008 Mar; 58(548):154-9. PubMed ID: 18318968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cuban programme for prevention of sickle cell disease.
    Granda H; Gispert S; Dorticós A; Martín M; Cuadras Y; Calvo M; Martínez G; Zayas MA; Oliva JA; Heredero L
    Lancet; 1991 Jan; 337(8734):152-3. PubMed ID: 1670797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Student screening for inherited blood disorders in Bahrain.
    Al-Arrayed S; Hafadh N; Amin S; Al-Mukhareq H; Sanad H
    East Mediterr Health J; 2003 May; 9(3):344-52. PubMed ID: 15751927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of thalassaemia in Cyprus.
    Angastiniotis MA; Hadjiminas MG
    Lancet; 1981 Feb; 1(8216):369-71. PubMed ID: 6109998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal prevention for severe thalassemia disease at Srinagarind Hospital.
    Ratanasiri T; Charoenthong C; Komwilaisak R; Changtrakul Y; Fucharoen S; Wongkham J; Kleebkaow P; Seejorn K
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S87-93. PubMed ID: 17725145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling.
    Colah R; Surve R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Satoskar P; Mohanty D
    Prenat Diagn; 2005 May; 25(5):345-9. PubMed ID: 15906420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia.
    Cao A; Furbetta M; Galanello R; Melis MA; Angius A; Ximenes A; Rosatelli C; Ruggeri R; Addis M; Tuveri T; Falchi AM; Paglietti E; Scalas MT
    Am J Hum Genet; 1981 Jul; 33(4):592-605. PubMed ID: 7258188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.